Publication | Open Access
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis
130
Citations
41
References
2018
Year
Regardless of past TKI therapy, therapeutic response and AEs after introducing LEN were similar. LEN may be an important treatment for the present unmet need regarding TKI treatment against u-HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1